Human type 3 3α-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells

Endocrinology

Volumn 144, Issue 7, 2003, Pages 2922-2932

  Rižner, Tea Lanišnik ^a,e   Lin, Hsueh K ^b   Peehl, Donna M ^c   Steckelbroeck, Stephan ^a   Bauman, David R ^a   Penning, Trevor M ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

11 CIS RETINAL; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTERONE; ESTROGEN; GESTAGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINOL DEHYDROGENASE; SEX HORMONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ANDROGEN METABOLISM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCURONIDATION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; ANDROSTANE-3,17-DIOL; ANIMALS; BONE NEOPLASMS; COS CELLS; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; MALE; PROSTATE; PROSTATIC NEOPLASMS; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0037661059     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0032     Document Type: Article

References (34)

1. Davies P, Eaton CL 1991 Regulation of prostate growth. J Endocrinol 131:5-17
2. Griffiths K, Morton MS 1999 Aspects of the cell biology of prostate cancer. In: Dunitz M, Malden MA, eds. Textbook of prostate cancer: pathology, diagnosis and treatment. London: Blackwell; 51-74
3. Russell DL, Wilson JD 1994 Steroid 5α-reductase two genes/two enzymes. Annu Rev Biochem 61:25-61
4. Hsing AW 2001 Hormones and prostate cancer: what's next. Epidemiol Rev 23:42-58
5. Bartsch W, Klein H, Schiemann U, Bauer HW, Voigt KD 1990 Enzymes of androgen formation and degradation in the human prostate. Annal NY Acad Sci 595:53-66
6. Span PN, Sweep CGJ, Benraad TJ, Smaals AGH 1996 3α-Hydroxysteroid oxidoreductase activities in dihydrotestosterone degradation and back-formation in rat prostate and epididymis. J Steroid Biochem Mol Biol 58:319-324
7. Biswas MG, Russell DW 1997 Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenase from rat and human prostate. J Biol Chem 272:15959-15966
8. Barbier O, Lapointe H, El Alfy M, Hum DW, Belanger A 2000 Cellular localization of uridine diphosphoglucronsyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistichemistry. J Clin Endocrinol Metab 85:4819-4826
9. 3H-5α-androstane-3β,17β-diol by human prostatic hypertrophy. Acta Endocrinol (Copenh) 79:394-402
10. Bruchovsky N 1971 Comparison of the metabolites formed in rat prostate following the in vivo administration of seven natural androgens. Endocrinology 89:1212-1222
11. Walsh PC, Wilson JD 1976 The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57:1093-1097
12. McDermott IR, Robinson CH, DeKlerk DP 1978 Studies of the effect of 5α-androstane-3α,17α-diol in the canine prostate in vivo. Steroids 31:511-521
13. Schultz FM, Wilson JD 1974 Virilization of the Wolffian duct in the rat fetus by various androgens, Endocrinology 94:979-986
14. Shaw G, Renfree MB, Leihy MW, Shackleton CHL, Roitman E, Wilson JD 2000 Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol. Proc Natl Acad Sci USA 97:12256-12259
15. Stoner E 1990 The clinical development of a 5α-reductase inhibitor, finasteride. J Steroid Biochem Mol Biol 37:375-378
16. Weiss RE, William R 1997 Management of prostate diseases. Caddo: Professional Communications; 41-108
17. Roehrborn CG, Bartsch G, Kirby R, Andriole G, Boyle P, de la Rossette J, Perrin P, Ramsey E, Nordling J, de Campos Freire G, Arap S 2001 Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative international overview. Urology 58:642-650
18. Penning TM, Burczynski ME, Jez JM, Hung C-F, Lin H-K, Ma H, Moore M, Palackal N, Ratnam K 2000 Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in inactivation and formation of male and female sex hormones. Biochem J 351:67-77
19. Chetyrkin SV, Hu J, Gough WH, Dumaual N, Kedishvili NY 2001 Further characterization of human microsomal 3α-hydroxysteroid dehydrogenase. Arch Biochem Biophys 386:1-10
20. Huang X-F, Luu-The V 2001 Characterization of the oxidative 3α-hydroxysteroid dehydrogenase activity of human recombinant 11-cis retinal dehydrogenase. Biochim Biophys Acta 1547:351-358
21. Huang X-F, Luu-The V 2001 Modulation of the androgenic response by recombinant human 11-cis retinal dehydrogenase. J Steroid Biochem Mol Biol 77:129-133
22. He X-Y, Merz G, Yang Y-Z, Pullakart R, Mehta P, Schultz H, Yang S-Y 2000 Function of human brain short-chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism. Biochim Biophys Acta 1484:267-277
23. Lin H-K, Jez JJ, Schlegel BP, Peehl DM, Pachter JA, Penning TM 1997 Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α/17β-HSD activity and cellular distribution. Mol Endocrinol 11:1971-1984
24. Burczynski ME, Harvey RG, Penning TM 1998 Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated ortho-quinone metabolite benzo[a]pyrene-7,8-dione. Biochemistry 37:6781-6790
25. Tsuruda L, Hou Y-T, Penning TM 2001 Stable expression of rat dihydrodiol dehydrogenase (AKR1C9) in human breast MCF-7 cells results in the formation of PAH-o-quinones and enzyme mediated cell death. Chem Res Toxicol 14:856-862
26. Peehl DM 1992 Culture of human prostate epithelial cells. In: Freshney RI, ed. Culture of epithelial cells. New York: Wiley & Sons; 159-180
27. Hara A, Taniguchi H, Nakayama T, Sawada H 1990 Purification of properties of multiple forms of dihydrodiol dehydroganse from human liver. J Biochem 108:250-254
28. Dufort I, Labrie F, Van Luu-The V 2001 Human types 1 and 3 3α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. J Clin Endocrinol Metab 86:841-846
29. Hardy DO, Ge R-S, Catterall JF, Hou T-T, Penning TM, Hardy MP 2000 Identification of the oxidative 3α-hydroxysteroid dehydrogenase activity of rat Leydig cells as type II retinol dehydrogenase. Endocrinology 141:1608-1617
30. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818
31. Castagnetta LA, Carruba G, Traina A, Granata OM, Markus M, Parone-Macaluso M, Blomquist CH, Adamski J 1997 Expression of different 17β-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cell types. Endocrinology 138:4876-4882
32. Guillemette C, Hum DW, Belanger A 1995 Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes. J Steroid Biochem Mol Biol 55:355-362
33. Debas JD, Tindall DJ 2002 The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187:1-7
34. Jez JM, Flynn G, Penning TM 1997 A new nomenclature for the aldo-keto reductase superfamily Biochem Pharmacol 54:639-647